University of Maryland Pharmacy Program Integrates AI to Advance Drug Development
By
May 28, 2026 | Emily Bleiweis
10h ago· 6 min readenNews
85/100
Golden Brown
Bagelometer↗
If you only eat one bagel today, this is the bagel.
Score85TypenewsSentimentpositive
Summary
The article discusses how the University of Maryland School of Pharmacy's MS program is integrating artificial intelligence to innovate drug development. It features Debi Hudgens, PhD, who was diagnosed with a rare renal disease and highlights the need for more therapeutics. The piece explores how AI is transforming pharmaceutical research, drug discovery, and development processes within pharmacy education and practice.
Key quotes
· 3 pulledThere's a lot of medications that still need to be developed. That's my dream — to go work in that space and really come up with new therapeutics.
Three years ago, Debi Hudgens, PhD, MBA, CLP, CA-AM, was diagnosed with a rare renal disease.
Hudgens is fortunate, she said — there are new medications that have come out in recent years that are helping.
University of Maryland School of Pharmacy's MS Program Shows How Artificial Intelligence Can Innovate Drug Development
